This letter to the editor focuses on a recent report of a retrospective case-control study of fluoropyrimidine-associated cardiotoxicity in patients with cancer.
Fluoropyrimidine-Associated Cardiotoxicity: Probably Not So Rare As It Seems
Berretta M.Ultimo
2020-01-01
Abstract
This letter to the editor focuses on a recent report of a retrospective case-control study of fluoropyrimidine-associated cardiotoxicity in patients with cancer.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
